Designed for decentralized clinical settings, the EHBT-50 Mini Lab combines 7-diff hematology, biochemistry, immunoassay, and AI-powered morphology analysis within an integrated diagnostic platform. The system was recognized in the Medical Technologies category for addressing growing demand for faster, more accessible diagnostics beyond centralized laboratories.

As diagnostic testing expands across frontline healthcare environments, laboratories are facing increasing pressure from staffing shortages, workflow complexity, and delayed turnaround times. In many distributed care settings, advanced morphology analysis still depends heavily on specialized personnel and centralized laboratory infrastructure. Ozelle's approach focuses on simplifying these workflows while maintaining laboratory-level analytical capability in everyday clinical practice.

The EHBT-50 Mini Lab incorporates Ozelle's AI × CBM (Complete Blood Morphology) technology to support standardized morphology analysis and rapid identification of abnormal cells. By combining AI-assisted interpretation with consistent cellular imaging, the system helps reduce dependence on highly specialized manual review in routine testing environments while improving consistency across different clinical settings.

For everyday clinical operation, the analyzer features maintenance-free architecture, sealed all-in-one cartridges, room-temperature reagents, and simplified one-click testing designed to reduce operational complexity. The system also supports flexible testing panels for applications including infection assessment, diabetes management, and thyroid testing, helping clinicians manage broader diagnostic needs without relying on multiple standalone analyzers.

Founded in Silicon Valley in 2014 and now operating globally with operations in Frankfurt, Ozelle develops AI- and IoT-powered diagnostic systems for medical and veterinary applications worldwide. "This recognition reflects the industry's growing focus on diagnostic systems that can operate reliably across real-world clinical environments," said Ozelle. "We believe hematology is entering a new phase where AI and morphology intelligence become more integrated into routine clinical workflows." Schedule a meeting to experience Ozelle's AI-powered diagnostics live.

Contact Ozelle
www.ozellemed.com
info@ozellepoct.com

AI Workbench: Turning Reports into Actionable Insights

At the center of Ozelle's on-site demonstrations is the Intelligent AI Workbench (Open Dx) — a unified diagnostic workspace embedded directly into the analyzer. It turns raw lab results into structured, interactive insights, guiding clinicians through actionable information.

Key features include risk stratification, conversational AI report interpretation, critical alerts, and follow-up trend analysis. By integrating test ordering, result review, and AI-assisted interpretation into a single, intuitive workflow, the workbench supports confident, efficient decisions without adding operational burden or extensive training.

Expanding Scenarios: From Routine Care to Malaria Risk Screening

Live demonstrations illustrate the system's versatility:

• Infection Profiling: CBC + CRP + SAA in a single automated run, with no manual reagent switching.
• Everyday Disease Management: Flexible, customizable panels for diabetes, cardiac, and thyroid monitoring, designed for repeatable, high-frequency use without adding workflow complexity.
• Malaria Risk Screening: AI-powered morphology analysis identifies red blood cell patterns associated with Plasmodium, providing high-, medium-, and low-risk indications for early screening and follow-up in endemic regions.

These scenario-ready capabilities demonstrate how Ozelle extends advanced morphology intelligence beyond routine CBC to support both everyday care and high-risk, public health applications.

AI × CBM: Validated, Reliable, and Easy to Use

At the foundation of Ozelle's system is AI-powered Complete Blood Morphology (CBM), which combines high-resolution imaging with real-time algorithmic analysis for deeper, actionable insights. Combined with a maintenance-free, easy-to-use device design, the system delivers long-term reliability, ideal for primary care clinics, chain laboratories, and decentralized testing sites.

Ozelle's technology is validated through 50,000+ global installations, generating 50 million+ cell images daily and over 100 billion real-world data points. Continuous algorithm refinement via an industry-exclusive quality control system ensures lab-grade performance that remains stable, scalable, and sustainable over time.

Visitors are welcome to experience live demonstrations, hands-on AI Workbench sessions, and in-depth discussions on distribution partnerships and regional deployment strategies with Ozelle. Schedule a meeting in advance to experience Ozelle's AI-powered diagnostics live.

Contact Ozelle
www.ozellemed.com
info@ozellepoct.com

AI × CBM: See More. Diagnose Smarter.

Ozelle's AI-powered Complete Blood Morphology (CBM) redefines hematology diagnostics by combining high-resolution imaging with real-time algorithmic analysis. Moving beyond traditional numerical data, the system identifies multi-classified cells—including NST, NSG, ALY, and RET—enabling earlier detection and more informed clinical decisions from a single drop of blood.

All-in-One Testing: Scenario-Driven, Flexible Panels

The solution integrates hematology, biochemistry, and immunoassay into a single, maintenance-free workflow. Clinicians can build flexible, on-demand panels tailored to specific scenarios: Infection typing (CBC+CRP+SAA), Diabetes care (CBC+HbA1c), and Cardiac screening (CBC+NT-proBNP), among others. This versatility empowers primary care clinics and pharmacies to deliver comprehensive results with unmatched efficiency.

Intelligent AI Workbench: From Results to Diagnostic Guidance

A key highlight at WHX Labs Dubai will be Ozelle's Intelligent AI Workbench (Open Dx), a unified diagnostic workbench built directly into the analyzer. The system seamlessly integrates test ordering, result review, and AI-assisted guidance into a single workflow, enabling clinicians to move efficiently from testing to interpretation with greater confidence.

The workbench transforms traditional static reports into interactive diagnostic insights by automatically identifying abnormal findings, flagging potential risks, and providing structured overview interpretations. Through conversational AI functionality, clinicians can further explore results via interactive report consultation. In veterinary applications, the AI Workbench also supports AI-assisted diagnostic guidance and medication references tailored specifically to animal care.

Global Scale, Validated Precision

Ozelle's AI capabilities are anchored by 50,000+ installations worldwide, generating over 50 million cell images daily. This database, exceeding 100 billion real-world data points, ensures continuously refined algorithms validated through an industry-exclusive quality control system.

Ozelle invites all attendees to WHX Labs Dubai (Booth S1.D58) for live demonstrations and interactive sessions to experience how AI × CBM is shaping the future of diagnostic testing. Leave a message to secure your meeting and experience it live. 

Contact Ozelle

www.ozellemed.com

info@ozellepoct.com